Mersana Therapeutics MRSN Stock
Mersana Therapeutics Price Chart
Mersana Therapeutics MRSN Financial and Trading Overview
| Mersana Therapeutics stock price | 29.08 USD |
| Previous Close | 29.08 USD |
| Open | 28.78 USD |
| Bid | 20.63 USD x 200 |
| Ask | 36.8 USD x 200 |
| Day's Range | 29.08 - 29.08 USD |
| 52 Week Range | 5.21 - 30.39 USD |
| Volume | 624.03K USD |
| Avg. Volume | 141.82K USD |
| Market Cap | 145.36M USD |
| Beta (5Y Monthly) | 0.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 30.75 USD |
MRSN Valuation Measures
| Enterprise Value | 91.27M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.617462 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.3810625 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 2.751 |
| Enterprise Value/EBITDA | -1.377 |
Trading Information
Mersana Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.43 |
| 52-Week Change | 111.52% |
| S&P500 52-Week Change | 21.96% |
| 52 Week High | 30.39 USD |
| 52 Week Low | 5.21 USD |
| 50-Day Moving Average | 23.98 USD |
| 200-Day Moving Average | 12.23 USD |
MRSN Share Statistics
| Avg. Volume (3 month) | 141.82K USD |
| Avg. Daily Volume (10-Days) | 192.51K USD |
| Shares Outstanding | 5M |
| Float | 3.53M |
| Short Ratio | 0.79 |
| % Held by Insiders | 1.46% |
| % Held by Institutions | 67.56% |
| Shares Short | 54.45K |
| Short % of Float | 1.19% |
| Short % of Shares Outstanding | 1.09% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | -211.21% |
| Operating Margin (ttm) | -67.90% |
| Gross Margin | -108.037% |
| EBITDA Margin | -199.78% |
Management Effectiveness
| Return on Assets (ttm) | -36.26% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 33.18M USD |
| Revenue Per Share (ttm) | 6.67 USD |
| Quarterly Revenue Growth (yoy) | -12.59% |
| Gross Profit (ttm) | -35847000 USD |
| EBITDA | -66290000 USD |
| Net Income Avi to Common (ttm) | -70081000 USD |
| Diluted EPS (ttm) | -13.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 56.39M USD |
| Total Cash Per Share (mrq) | 11.28 USD |
| Total Debt (mrq) | 2.29M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.386 |
| Book Value Per Share (mrq) | -11.911 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -74371000 USD |
| Levered Free Cash Flow (ttm) | -43801248 USD |
Profile of Mersana Therapeutics
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 840 Memorial Drive |
| ZIP | 02139 |
| Phone | 617 498 0020 |
| Website | https://www.mersana.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 102 |
Mersana Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops antibody-drug conjugates (ADC) for cancer patients with unmet needs. The company develops Emi-Le (XMT-1660), a B7-H4-targeting Dolasynthen ADC candidate, which is in Phase 1 clinical trial; and XMT-2056, an Immunosynthen ADC targeting a novel human epidermal growth factor receptor 2 that is in Phase 1 clinical trial. Its preclinical products portfolio includes XMT-2068 and XMT-2175. It has strategic research and development collaborations with Janssen Biotech, Inc., Ares Trading S.A., Merck KGaA, and Asana Biosciences, LLC for the development of ADC product candidates. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts. As of January 6, 2026, Mersana Therapeutics, Inc. operates as a subsidiary of Day One Biopharmaceuticals, Inc.
Q&A For Mersana Therapeutics Stock
What is a current MRSN stock price?
Mersana Therapeutics MRSN stock price today per share is 29.08 USD.
How to purchase Mersana Therapeutics stock?
You can buy MRSN shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Mersana Therapeutics?
The stock symbol or ticker of Mersana Therapeutics is MRSN.
Which industry does the Mersana Therapeutics company belong to?
The Mersana Therapeutics industry is Biotechnology.
How many shares does Mersana Therapeutics have in circulation?
The max supply of Mersana Therapeutics shares is 5M.
What is Mersana Therapeutics Price to Earnings Ratio (PE Ratio)?
Mersana Therapeutics PE Ratio is 0.00000000 now.
What was Mersana Therapeutics earnings per share over the trailing 12 months (TTM)?
Mersana Therapeutics EPS is 0 USD over the trailing 12 months.
Which sector does the Mersana Therapeutics company belong to?
The Mersana Therapeutics sector is Healthcare.
Mersana Therapeutics MRSN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Select Market Com NQGS | 13180.97 USD — |
-0.87
|
— — | 13139.79 USD — | 13316.81 USD — | — - | — — |
| US Tech Biotechnology NBI | 5807.22 USD — |
+1.87
|
— — | 5685.34 USD — | 5809.82 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}